Analyzing Factors that Link Chronic Rhinosinusitis & Gastroesophageal Reflux Disease

Analyzing Factors that Link Chronic Rhinosinusitis & Gastroesophageal Reflux Disease

0.5 hours | ACCME, ANCC

COURSE DESCRIPTION

Recent data indicate that more than 10 million Americans have chronic rhinosinusitis (CRS), an inflammatory disease that is associated with $50 to $60 billion in annual healthcare costs. With no optimal treatment, quality of life in patients with CRS is generally poor. Prior research has also shown that 11% to 15% of patients with CRS also have GERD or reflux, making this disease much more common in CRS patients than in the general population. Reflux affects sinusitis in these patients, making it nearly refractory to therapy, therefore making GERD an important topic to study in the setting of CRS.

Activities Included:

CME Information

Content

Quiz

Evaluation

Standard: Free

Ulcerative Colitis Treatments: Comparing Mortality

Ulcerative Colitis Treatments: Comparing Mortality

0.5 hours | ACCME, ANCC

COURSE DESCRIPTION

While medical therapy is generally safe for people with ulcerative colitis (UC), only about one-third of patients experience a long-term response to medications. Patients also must endure a trial-and-error approach until they find a medication that works for them, which can severely impact quality of life (QOL). In addition, some UC medications come with higher risks of serious side effects. As an alternative to medical therapy, patients with UC can undergo elective colectomy. Surgery has always been an option for patients with UC, but it is often viewed as a last resort. Research now shows that elective colectomy is associated with low morbidity and mortality, but it may also alter patients’ QOL following the procedure

Activities Included:

CME Information

Content

Quiz

Evaluation

Standard: Free